36 min listen
Biopharma PR 101 with Matt Middleman, M.D.
ratings:
Length:
37 minutes
Released:
Jul 5, 2021
Format:
Podcast episode
Description
When is the appropriate time for a new life sciences company to wind up the PR machine? What's the difference between public and investor relations, and how do they complement each other? What's newsworthy? What's not? What are the latest tools of the trade in an increasingly social-driven PR practice? What results should you expect, and how are those results measured? On this episode of the Business of Biotech, we address these questions with physician and professor-turned public relations practitioner extraordinaire Matt Middleman, M.D. , founding partner and CEO at LifeSci Communications, LLC.
Released:
Jul 5, 2021
Format:
Podcast episode
Titles in the series (100)
005: Building A Biotech All-Star Team With Vivek Ramaswamy by Business Of Biotech